Spinal Muscular Atrophy Type III
Cross-source consensus on Spinal Muscular Atrophy Type III from 1 sources and 3 claims.
1 sources · 3 claims
How it works
Risks & contraindications
Background
Highlighted claims
- Spinal muscular atrophy is caused by biallelic inactivation of the SMN1 gene and leads to SMN protein deficiency. — Effects of physical therapy on motor ability in patients with spinal muscular atrophy III: a study protocol for a randomised controlled trial
- SMA type III usually begins after 18 months of age, and most affected children achieve independent walking. — Effects of physical therapy on motor ability in patients with spinal muscular atrophy III: a study protocol for a randomised controlled trial
- About half of people with SMA type III lose independent ambulation by their second decade of life. — Effects of physical therapy on motor ability in patients with spinal muscular atrophy III: a study protocol for a randomised controlled trial